Patents by Inventor Louis John Papa

Louis John Papa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11414677
    Abstract: Disclosed herein are methods of performing continuous directed evolution in complex biological systems, including metazoan cells. These methods include the infection of engineered, non-naturally occurring metazoan cells with engineered, non-naturally occurring DNA viruses. The generation of infectious viruses that can infect new cells depends on the evolution of a gene of interest which is driven by an error-prone adenoviral polymerase. Also disclosed herein, are the compositions of engineered, non-naturally occurring metazoan cells and engineered, non-naturally occurring DNA viruses that function as components in the continuous directed evolution methodologies.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: August 16, 2022
    Assignee: Massachusetts Institute of Technology
    Inventors: Matthew D. Shoulders, Chet Berman, Christopher Lawrence Moore, Louis John Papa, Samuel Joseph Hendel
  • Publication number: 20190309284
    Abstract: Disclosed herein are methodologies and kits for dynamic targeted hypermutation that harness the enzymatic activity of a polynucleic acid-binding protein fused to a nucleobase-editing enzyme to specifically target mutations across a region of interest. These methodologies and kits facilitate the rapid creation of diverse DNA libraries in vivo or in vitro.
    Type: Application
    Filed: March 19, 2019
    Publication date: October 10, 2019
    Applicant: Massachusetts Institute of Technology
    Inventors: Matthew D. Shoulders, Louis John Papa, Christopher Lawrence Moore
  • Publication number: 20190153472
    Abstract: Disclosed herein are methods of performing continuous directed evolution in complex biological systems, including metazoan cells. These methods include the infection of engineered, non-naturally occurring metazoan cells with engineered, non-naturally occurring DNA viruses. The generation of infectious viruses that can infect new cells depends on the evolution of a gene of interest which is driven by an error-prone adenoviral polymerase. Also disclosed herein, are the compositions of engineered, non-naturally occurring metazoan cells and engineered, non-naturally occurring DNA viruses that function as components in the continuous directed evolution methodologies.
    Type: Application
    Filed: October 26, 2018
    Publication date: May 23, 2019
    Applicant: Massachusetts Institute of Technology
    Inventors: Matthew D. Shoulders, Chet Berman, Christopher Lawrence Moore, Louis John Papa, Samuel Joseph Hendel